BlackRock Fund Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$61M	Buy	1,217,898 +137,655	+13%	+$7.23M	0.01%	1550
2016 Q3	$56.7M	Buy	1,080,243 +71,528	+7%	+$3.42M	0.01%	1488
2016 Q2	$41.7M	Buy	1,008,715 +64,281	+7%	+$2.8M	0.01%	1611
2016 Q1	$38.4M	Buy	944,434 +15,566	+2%	+$535K	0.01%	1607
2015 Q4	$38.5M	Sell	928,868 -4,806	-0.5%	-$161K	0.01%	1655
2015 Q3	$14.4M	Buy	933,674 +36,189	+4%	+$778K	﹤0.01%	2199
2015 Q2	$22.3M	Buy	897,485 +11,247	+1%	+$251K	0.01%	2044
2015 Q1	$20.3M	Buy	886,238 +156,746	+21%	+$3.96M	﹤0.01%	2060
2014 Q4	$19.7M	Buy	729,492 +316,886	+77%	+$5.45M	﹤0.01%	2075
2014 Q3	$4.84M	Sell	412,606 -10,816	-3%	-$136K	﹤0.01%	2774
2014 Q2	$6.58M	Buy	423,422 +231,131	+120%	+$3.31M	﹤0.01%	2672
2014 Q1	$3.78M	Buy	192,291 +42,598	+28%	+$723K	﹤0.01%	2970
2013 Q4	$2.51M	Buy	+149,693	New	+$1.86M	﹤0.01%	3107